BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37550825)

  • 1. O-RADS MRI SCORE: An Essential First-Step Tool for the Characterization of Adnexal Masses.
    Thomassin-Naggara I; Dabi Y; Florin M; Saltel-Fulero A; Manganaro L; Bazot M; Razakamanantsoa L
    J Magn Reson Imaging; 2024 Mar; 59(3):720-736. PubMed ID: 37550825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Added Value of Quantitative Analysis of Diffusion-Weighted Imaging in Ovarian-Adnexal Reporting and Data System Magnetic Resonance Imaging.
    Hottat NA; Badr DA; Van Pachterbeke C; Vanden Houte K; Denolin V; Jani JC; Cannie MM
    J Magn Reson Imaging; 2022 Jul; 56(1):158-170. PubMed ID: 34797013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to improve O-RADS MRI score for rating adnexal masses with cystic component?
    Assouline V; Dabi Y; Jalaguier-Coudray A; Stojanovic S; Millet I; Reinhold C; Bazot M; Thomassin-Naggara I;
    Eur Radiol; 2022 Sep; 32(9):5943-5953. PubMed ID: 35332409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving risk stratification of indeterminate adnexal masses on MRI: What imaging features help predict malignancy in O-RADS MRI 4 lesions?
    Wong BZY; Causa Andrieu PI; Sonoda Y; Chi DS; Aviki EM; Vargas HA; Woo S
    Eur J Radiol; 2023 Nov; 168():111122. PubMed ID: 37806193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. O-RADS MRI: A Systematic Review and Meta-Analysis of Diagnostic Performance and Category-wise Malignancy Rates.
    Rizzo S; Cozzi A; Dolciami M; Del Grande F; Scarano AL; Papadia A; Gui B; Gandolfo N; Catalano C; Manganaro L
    Radiology; 2023 Apr; 307(1):e220795. PubMed ID: 36413127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. O-RADS MRI score: analysis of misclassified cases in a prospective multicentric European cohort.
    Thomassin-Naggara I; Belghitti M; Milon A; Abdel Wahab C; Sadowski E; Rockall AG;
    Eur Radiol; 2021 Dec; 31(12):9588-9599. PubMed ID: 34041567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of American College of Radiology Ovarian-Adnexal Reporting and Data System Ultrasound (O-RADS US): Analysis on 1054 adnexal masses.
    Cao L; Wei M; Liu Y; Fu J; Zhang H; Huang J; Pei X; Zhou J
    Gynecol Oncol; 2021 Jul; 162(1):107-112. PubMed ID: 33966893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian-Adnexal Reporting Data System Magnetic Resonance Imaging (O-RADS MRI) Score for Risk Stratification of Sonographically Indeterminate Adnexal Masses.
    Thomassin-Naggara I; Poncelet E; Jalaguier-Coudray A; Guerra A; Fournier LS; Stojanovic S; Millet I; Bharwani N; Juhan V; Cunha TM; Masselli G; Balleyguier C; Malhaire C; Perrot NF; Sadowski EA; Bazot M; Taourel P; Porcher R; Darai E; Reinhold C; Rockall AG
    JAMA Netw Open; 2020 Jan; 3(1):e1919896. PubMed ID: 31977064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic Review and Meta-Analysis of O-RADS Ultrasound and O-RADS MRI for Risk Assessment of Ovarian and Adnexal Lesions.
    Zhang Q; Dai X; Li W
    AJR Am J Roentgenol; 2023 Jul; 221(1):21-33. PubMed ID: 36722758
    [No Abstract]   [Full Text] [Related]  

  • 10. Accuracy and reproducibility of the O-RADS MRI risk stratification system based on enhanced non-DCE MRI in the assessment of adnexal masses.
    Wu M; Tang Q; Cai S; Zhu L; Lin C; Guan Y; Rao S; Zhou J
    Eur J Radiol; 2023 Feb; 159():110670. PubMed ID: 36584564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. O-RADS MRI scoring system has the potential to reduce the frequency of avoidable adnexal surgery.
    Dabi Y; Rockall A; Razakamanantsoa L; Guerra A; Fournier LS; Fotopoulou C; Touboul C; Thomassin-Naggara I;
    Eur J Obstet Gynecol Reprod Biol; 2024 Mar; 294():135-142. PubMed ID: 38237312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MR imaging of the Adnexa: Technique and Imaging Acquisition.
    Rockall AG; Jalaguier-Coudray A; Thomassin-Naggara I
    Magn Reson Imaging Clin N Am; 2023 Feb; 31(1):149-161. PubMed ID: 36368859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bridging Communication Gaps Between Radiologists, Referring Physicians, and Patients Through Standardized Structured Cancer Imaging Reporting: The Experience with Female Pelvic MRI Assessment Using O-RADS and a Simulated Cohort Patient Group.
    Woo S; Andrieu PC; Abu-Rustum NR; Broach V; Zivanovic O; Sonoda Y; Chi DS; Aviki E; Ellis A; Carayon P; Hricak H; Vargas HA
    Acad Radiol; 2024 Apr; 31(4):1388-1397. PubMed ID: 37661555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of IOTA Simple Rules, Simple Rules risk assessment, ADNEX model and O-RADS in differentiating between benign and malignant adnexal lesions in North American women.
    Hiett AK; Sonek JD; Guy M; Reid TJ
    Ultrasound Obstet Gynecol; 2022 May; 59(5):668-676. PubMed ID: 34533862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic accuracy and validity of the O-RADS MRI score based on a simplified MRI protocol: a single tertiary center retrospective study.
    Aslan S; Tosun SA
    Acta Radiol; 2023 Jan; 64(1):377-386. PubMed ID: 34839677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Performance of Ultrasonography-Based Risk Models in Differentiating Between Benign and Malignant Ovarian Tumors in a US Cohort.
    Yoeli-Bik R; Longman RE; Wroblewski K; Weigert M; Abramowicz JS; Lengyel E
    JAMA Netw Open; 2023 Jul; 6(7):e2323289. PubMed ID: 37440228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. O-RADS combined with contrast-enhanced ultrasound in risk stratification of adnexal masses.
    Shi Y; Li H; Wu X; Li X; Yang M
    J Ovarian Res; 2023 Aug; 16(1):153. PubMed ID: 37537697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. External Validation of O-RADS US Risk Stratification and Management System.
    Hack K; Gandhi N; Bouchard-Fortier G; Chawla TP; Ferguson SE; Li S; Kahn D; Tyrrell PN; Glanc P
    Radiology; 2022 Jul; 304(1):114-120. PubMed ID: 35438559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. External Validation of the Ovarian-Adnexal Reporting and Data System (O-RADS) Lexicon and the International Ovarian Tumor Analysis 2-Step Strategy to Stratify Ovarian Tumors Into O-RADS Risk Groups.
    Timmerman S; Valentin L; Ceusters J; Testa AC; Landolfo C; Sladkevicius P; Van Holsbeke C; Domali E; Fruscio R; Epstein E; Franchi D; Kudla MJ; Chiappa V; Alcazar JL; Leone FPG; Buonomo F; Coccia ME; Guerriero S; Deo N; Jokubkiene L; Kaijser J; Scambia G; Andreotti R; Timmerman D; Bourne T; Van Calster B; Froyman W
    JAMA Oncol; 2023 Feb; 9(2):225-233. PubMed ID: 36520422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. O-RADS scoring system for adnexal lesions: Diagnostic performance on TVUS performed by an expert sonographer and MRI.
    Campos A; Villermain-Lécolier C; Sadowski EA; Bazot M; Touboul C; Razakamanantsoa L; Thomassin-Naggara I
    Eur J Radiol; 2023 Dec; 169():111172. PubMed ID: 37976101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.